Tuesday, December 18, 2018

5 hours ago - H.R. 5554 Improves Animal Drug and Food Ingredient Approvals. New law will help streamline the approvals process and spur innovation. H.R. 5554 Improves

FDA Puts Chinese Manufacturer on Import Alert

Pharmaceutical Technology Magazine-1 hour ago
... where it is exposed to vermin, animal waste, and various contaminants … ... According to FDA, the company did not test finished drug products for total aerobi

Comprehensive Framework Is Established for Antibiotic Stewardship ...

The Pew Charitable Trusts (blog)-19 hours ago
Antibiotics are fundamental to human and animal health. How these vital drugs are used in any setting, however, must be carefully managed to limit the ...

FDA works with Pfizer to reduce drug shortage

Today's Veterinary Business Magazine-4 hours ago
Veterinary practices struggling to stock enough injectable opioids for patient pain control could see some relief under a new U.S. Food and Drug Administration ...
FDA, Pfizer helping alleviate opioid shortage
VeterinaryPracticeNews.com-4 hours ago

Statement from FDA Commissioner Scott Gottlieb, MD on the FDA's ...

FDA.gov-7 hours ago
Today, I'd like to focus on how we're addressing AMR in the context of veterinaryantimicrobial drugs and their use in food-producing animals. The FDA's Center ...
Global Market for Animal Antibiotics and Antimicrobials to Record ...
Daily Industry Updates (press release) (blog)-12 hours ago
Fentanyl is now the deadliest drug in America, federal health officials say
USA TODAY
Fentanyl is now the deadliest drug in America, federal health officials announced Wednesday, with over 18,000 overdose deaths in 2016. Read the full story

Pfizer again supplying pain drugs to veterinarians shunted aside because of hospital shortages

UPDATE: Pharmacy board votes against moving CBD oil plant from ...

WCYB-4 hours ago
Earlier this year, the board of pharmacy granted 5 applications across the state to produce and distribute CBD oil. Dharma pharmaceuticals won the conditional .

"DOJ will take “swift” and “fierce” action against compounders who prepare drugs in insanitary conditions or otherwise out of compliance with ...."

quoted from James Burnham, the Deputy Assistant Attorney General for the Consumer Protection Branch (“CPB”), addressed the annual Food and Drug Law Institute Conference (“FDLI”) on December 13, 2018 about DOJ’s enforcement priorities and tools in the FDA-regulated space found at https://www.lexology.com/library/detail.aspx?g=d19dbf08-38dd-4978-ac79-e86421eed158

DOJ Official Outlines Enforcement Priorities Under the Food, Drug ...

Lexology-10 hours ago
Enforcement Priorities. Burnham focused on four general issues CPB currently is targeting for potential enforcement under the FDCA. Compounding Pharmacies.
11/30/2018CAO Medical Equipment Co., Ltd.Center for Drug Evaluation and ResearchCGMP/Finished Pharmaceuticals/AdulteratedNot Issued *

Monday, December 17, 2018

Opioid Crisis: The lawsuits that could bankrupt manufacturers and ...

CBS News-21 hours ago
Burton LeBlanc: And I can actually tell you which distributor distributed to which particular pharmacy, by year, by volume, and where the pills came from.

Daily Dicta: In Meningitis Pharmacy Case, 11 Guilty and One Acquittal ...

Law.com-54 minutes ago
And pharmacist Joseph Matthew “Matt” Evanosky was “absolutely innocent,” Pearlstein said, wrongly caught up when the feds indicted 14 people in connection ...

Pharmacist Groups Urge Federal Judge to Stop CVS-Aetna Merger

Pharmacy Times-8 minutes ago
Even though the deal received Department of Justice (DOJ) clearance, several pharmacy associations, as well as the American Medical Association and patient ...

Pharmacy owner convicted in Medicare fraud scheme

MD Linx-4 hours ago
December 14, 2018, Washington DC—A federal jury in Los Angeles, CA found a pharmacy owner guilty today for her role in a Medicare fraud scheme involving ..

IMPRIMIS PHARMACEUTICALS, INC. (NASDAQ:IMMY) Files An 8-K ...

Market Exclusive-10 hours ago
Imprimis Pharmaceuticals, Inc. (Imprimis) is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates ...